Financial Counselors Inc Becton Dickinson & CO Transaction History

Financial Counselors Inc

  • $6.76 Billion
  • Q4 2024

A detailed history of Financial Counselors Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Financial Counselors Inc holds 20,888 shares of BDX stock, worth $4.79 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
20,888
Previous 1,107 1786.9%
Holding current value
$4.79 Million
Previous $266,000 1681.2%
% of portfolio
0.07%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$220.02 - $243.75 $4.35 Million - $4.82 Million
19,781 Added 1786.9%
20,888 $4.74 Million
Q3 2024

Nov 13, 2024
SELL
$221.47 - $242.41 $36,542 - $39,997
-165 Reduced 12.97%
1,107 $266,000
Q2 2024

Aug 01, 2024
SELL
$225.07 - $246.17 $54,692 - $59,819
-243 Reduced 16.04%
1,272 $297,000
Q1 2024

May 02, 2024
BUY
$233.45 - $247.73 $39,453 - $41,866
169 Added 12.56%
1,515 $374,000
Q4 2023

Jan 26, 2024
SELL
$232.24 - $267.23 $5,806 - $6,680
-25 Reduced 1.82%
1,346 $328,000
Q3 2023

Nov 07, 2023
BUY
$254.9 - $283.59 $52,509 - $58,419
206 Added 17.68%
1,371 $354,000
Q2 2023

Jul 27, 2023
BUY
$238.39 - $265.32 $19,786 - $22,021
83 Added 7.67%
1,165 $308,000
Q1 2023

May 02, 2023
SELL
$229.71 - $259.35 $390,736 - $441,154
-1,701 Reduced 61.12%
1,082 $268,000
Q4 2022

Feb 14, 2023
BUY
$218.29 - $256.91 $5,238 - $6,165
24 Added 0.87%
2,783 $708,000
Q3 2022

Nov 01, 2022
SELL
$51.03 - $264.23 $1,020 - $5,284
-20 Reduced 0.72%
2,759 $615,000
Q2 2022

Aug 02, 2022
BUY
$234.74 - $275.42 $406,569 - $477,027
1,732 Added 165.43%
2,779 $685,000
Q1 2022

Apr 28, 2022
BUY
$243.64 - $270.48 $19,491 - $21,638
80 Added 8.27%
1,047 $279,000
Q4 2021

Feb 10, 2022
SELL
$230.08 - $250.94 $457,859 - $499,370
-1,990 Reduced 67.3%
967 $243,000
Q3 2021

Oct 26, 2021
BUY
$232.72 - $256.47 $4,887 - $5,385
21 Added 0.72%
2,957 $727,000
Q2 2021

Aug 03, 2021
SELL
$232.65 - $254.58 $16,052 - $17,566
-69 Reduced 2.3%
2,936 $714,000
Q1 2021

Apr 29, 2021
SELL
$232.09 - $256.88 $247,175 - $273,577
-1,065 Reduced 26.17%
3,005 $731,000
Q4 2020

Feb 10, 2021
SELL
$221.92 - $245.94 $307,137 - $340,380
-1,384 Reduced 25.38%
4,070 $1.02 Million
Q3 2020

Nov 16, 2020
SELL
$215.77 - $276.76 $498,644 - $639,592
-2,311 Reduced 29.76%
5,454 $1.27 Million
Q2 2020

Aug 07, 2020
BUY
$219.9 - $263.41 $1.18 Million - $1.41 Million
5,356 Added 222.33%
7,765 $1.86 Million
Q1 2020

Apr 23, 2020
BUY
$195.69 - $279.01 $23,091 - $32,923
118 Added 5.15%
2,409 $554,000
Q4 2019

Jan 31, 2020
SELL
$236.45 - $266.82 $58,403 - $65,904
-247 Reduced 9.73%
2,291 $623,000
Q3 2019

Nov 08, 2019
SELL
$230.58 - $256.08 $72,863 - $80,921
-316 Reduced 11.07%
2,538 $642,000
Q2 2019

Aug 14, 2019
SELL
$217.4 - $246.08 $34,784 - $39,372
-160 Reduced 5.31%
2,854 $719,000
Q1 2019

May 10, 2019
BUY
$206.05 - $248.17 $135,374 - $163,047
657 Added 27.87%
3,014 $753,000
Q4 2018

Feb 01, 2019
SELL
$204.73 - $257.93 $20,882 - $26,308
-102 Reduced 4.15%
2,357 $531,000
Q3 2018

Oct 30, 2018
SELL
$233.07 - $256.0 $38,456 - $42,240
-165 Reduced 6.29%
2,459 $642,000
Q2 2018

Aug 03, 2018
SELL
$208.1 - $233.85 $17,272 - $19,409
-83 Reduced 3.07%
2,624 $629,000
Q1 2018

Apr 26, 2018
SELL
$205.46 - $240.27 $25,682 - $30,033
-125 Reduced 4.41%
2,707 $587,000
Q4 2017

Feb 12, 2018
BUY
$189.0 - $222.64 $10,962 - $12,913
58 Added 2.09%
2,832 $606,000
Q3 2017

Nov 13, 2017
SELL
$186.89 - $198.9 $57,188 - $60,863
-306 Reduced 9.94%
2,774 $544,000
Q2 2017

Aug 10, 2017
BUY
N/A
3,080
3,080 $601,000

Others Institutions Holding BDX

# of Institutions
1,808
Shares Held
260M
Call Options Held
1.27M
Put Options Held
1.09M
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Financial Counselors Inc Portfolio

Follow Financial Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email